Publicaciones en colaboración con investigadores/as de John Radcliffe Hospital (20)

2012

  1. Bortezomib action in multiple myeloma: MicroRNA-mediated synergy (and miR-27a/CDK5 driven sensitivity)?

    Blood Cancer Journal

  2. Inter- and intra-observational variability in immunohistochemistry: A multicentre analysis of diffuse large B-cell lymphoma staining

    Histopathology, Vol. 61, Núm. 1, pp. 18-25

2011

  1. CD4-positive T-helper cell responses to the PASD1 protein in patients with diffuse large B-cell lymphoma

    Haematologica, Vol. 96, Núm. 1, pp. 78-86

  2. Identification and characterization of peripheral T-cell lymphoma-associated SEREX antigens

    PLoS ONE, Vol. 6, Núm. 8

  3. MicroRNA expression in multiple myeloma is associated with genetic subtype, isotype and survival

    Biology Direct, Vol. 6

2010

  1. MicroRNA expression in Sézary syndrome: Identification, function, and diagnostic potential

    Blood, Vol. 116, Núm. 7, pp. 1105-1113

2009

  1. Aberrant expression of microRNA biosynthetic pathway components is a common feature of haematological malignancy

    British Journal of Haematology

  2. Cytolytic T-cell response to the PASD1 cancer testis antigen in patients with diffuse large B-cell lymphoma

    British Journal of Haematology, Vol. 146, Núm. 4, pp. 396-407

  3. Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma

    Journal of Cellular and Molecular Medicine, Vol. 13, Núm. 7, pp. 1248-1260

  4. Expression profiling of persistent polyclonal B-cell lymphocytosis suggests constitutive expression of the AP-1 transcription complex and downregulation of Fas-apoptotic and TGFβ signalling pathways

    Leukemia, Vol. 23, Núm. 3, pp. 581-583

  5. MicroRNA expression in chronic lymphocytic leukaemia

    British Journal of Haematology

2008

  1. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma

    British Journal of Haematology, Vol. 141, Núm. 5, pp. 672-675

  2. MicroRNA expression in lymphocyte development and malignancy

    Leukemia

2007

  1. Gene expression profiling of CD34 + cells in patients with the 5q- syndrome

    British Journal of Haematology, Vol. 139, Núm. 4, pp. 578-589

  2. MORC4, a novel member of the MORC family, is highly expressed in a subset of diffuse large B-cell lymphomas

    British Journal of Haematology, Vol. 138, Núm. 4, pp. 479-486

  3. MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma

    International Journal of Cancer, Vol. 121, Núm. 5, pp. 1156-1161

2006

  1. Cancer-associated carbohydrate identification in Hodgkin's lymphoma by carbohydrate array profiling

    International Journal of Cancer, Vol. 118, Núm. 12, pp. 3161-3166

2005

  1. Investigation of the mechanisms of anti-complement activity in Ixodes ricinus ticks

    Molecular Immunology, Vol. 42, Núm. 1, pp. 31-38

2004

  1. Ixodid and Argasid Tick Species and West Nile Virus

    Emerging Infectious Diseases, Vol. 10, Núm. 4, pp. 653-657

  2. Susceptibility of mosquito and tick cell lines to infection with various flaviviruses

    Medical and Veterinary Entomology, Vol. 18, Núm. 3, pp. 268-274